finder.com

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cardlytics stock

Own Cardlytics stock in just a few minutes.

Buy Cardlytics (CDLX)
Avatar
Jing Jun Ma
Posted
Fact checked

Cardlytics, Inc is an internet content & information business based in the US. Cardlytics shares (CDLX) are listed on the NASDAQ and all prices are listed in US Dollars. Cardlytics employs 471 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Cardlytics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CDLX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

What's in this guide?

  1. CDLX shares summary
  2. Compare share dealing platforms
  3. Is CDLX stock a buy or sell?
  4. Stock performance over time
  5. Can I short CDLX shares?
  6. Cardlytics's financials
  7. How volatile are CDLX shares?
  8. Does Cardlytics pay a dividend?
  9. Other common questions

Cardlytics share price

Use our graph to track the performance of CDLX stocks over time.

Cardlytics shares at a glance

Information last updated 2021-04-29.
52-week range$42.14 - $161.47
50-day moving average $121.48
200-day moving average $121.51
Wall St. target price$143.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.49

Buy Cardlytics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Go to site
More Info
Robinhood
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Go to site
More Info
Interactive Brokers
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Go to site
More Info
Webull
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Go to site
More Info
Public
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
Go to site
More Info
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cardlytics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Cardlytics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cardlytics financials

Revenue TTM $186.9 million
Gross profit TTM $64 million
Return on assets TTM -9.84%
Return on equity TTM -36.89%
Profit margin -29.65%
Book value $5.64
Market capitalisation $4.5 billion

TTM: trailing 12 months

Shorting Cardlytics shares

There are currently 2.8 million Cardlytics shares held short by investors – that's known as Cardlytics's "short interest". This figure is 4.7% down from 2.9 million last month.

There are a few different ways that this level of interest in shorting Cardlytics shares can be evaluated.

Cardlytics's "short interest ratio" (SIR)

Cardlytics's "short interest ratio" (SIR) is the quantity of Cardlytics shares currently shorted divided by the average quantity of Cardlytics shares traded daily (recently around 451300). Cardlytics's SIR currently stands at 6.22. In other words for every 100,000 Cardlytics shares traded daily on the market, roughly 6220 shares are currently held short.

However Cardlytics's short interest can also be evaluated against the total number of Cardlytics shares, or, against the total number of tradable Cardlytics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cardlytics's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Cardlytics shares in existence, roughly 90 shares are currently held short) or 0.1061% of the tradable shares (for every 100,000 tradable Cardlytics shares, roughly 106 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cardlytics.

Find out more about how you can short Cardlytics stock.

Cardlytics share dividends

We're not expecting Cardlytics to pay a dividend over the next 12 months.

Cardlytics share price volatility

Over the last 12 months, Cardlytics's shares have ranged in value from as little as $42.14 up to $161.47. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cardlytics's is 2.5451. This would suggest that Cardlytics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Cardlytics overview

Cardlytics, Inc. operates an advertising platform within financial institutions digital channels that include online, mobile, email, and various real-time notifications in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. .

  1. Technical analysis graphic from TradingView, https://uk.tradingview.com Stock prices and other date from EOD Historical Data

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site